Elisabet
Guruceaga Martínez
Bioinformática
Hospital Virgen del Camino
Pamplona, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Virgen del Camino (4)
2021
-
Delta-24-RGD, an oncolytic adenovirus, increases survival and promotes proinflammatory immune landscape remodeling in models of AT/RT and CNS-PNET
Clinical Cancer Research, Vol. 27, Núm. 6, pp. 1807-1820
2020
-
A novel FTY720 analogue targets SET-PP2A interaction and inhibits growth of acute myeloid leukemia cells without inducing cardiac toxicity
Cancer Letters, Vol. 468, pp. 1-13
2014
-
A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool
Neuro-Oncology, Vol. 16, Núm. 4, pp. 520-527
-
MiRNA cargo within exosome-like vesicle transfer influences metastatic bone colonization
Molecular Oncology, Vol. 8, Núm. 3, pp. 689-703